2014
DOI: 10.1002/2052-2975.32
|View full text |Cite
|
Sign up to set email alerts
|

Actinobaculum schaalii: identification with MALDI-TOF

Abstract: Actinobaculum schaalii is an emerging uropathogen. So far, its identification has been performed with 16S rRNA gene sequencing or PCR. The diagnosis has often been delayed due to fastidious growth and identification problems. Eleven clinical isolates of A. schaalii from bloodstream infections that were initially identified with 16S rRNA sequencing analysis were recovered and later identified with matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF). We presen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
24
0

Year Published

2015
2015
2017
2017

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 26 publications
(25 citation statements)
references
References 16 publications
1
24
0
Order By: Relevance
“…As there is no commercially available biochemical identification system that reliably identifies this bacteria, diagnosis is made with molecular methods, usually by 16S rRNA gene sequencing, or by MALDI-TOF MS [1,10,11]. In one study, the investigators were able to reliably identify A. schaalii in 11 of 11 clinical isolates using MALDI-TOF MS with Bruker Biotyper scores above 2.0, which is considered a score compatible with accurate species level identification [10].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…As there is no commercially available biochemical identification system that reliably identifies this bacteria, diagnosis is made with molecular methods, usually by 16S rRNA gene sequencing, or by MALDI-TOF MS [1,10,11]. In one study, the investigators were able to reliably identify A. schaalii in 11 of 11 clinical isolates using MALDI-TOF MS with Bruker Biotyper scores above 2.0, which is considered a score compatible with accurate species level identification [10].…”
Section: Discussionmentioning
confidence: 99%
“…In one study, the investigators were able to reliably identify A. schaalii in 11 of 11 clinical isolates using MALDI-TOF MS with Bruker Biotyper scores above 2.0, which is considered a score compatible with accurate species level identification [10]. Farfour evaluated the use of MALDI in identifying GPB, with 16S rRNA gene sequencing as the reference identification technique, and the investigators were able to correctly identify A. schaalii in 100% of their isolates [11].…”
Section: Discussionmentioning
confidence: 99%
“…The unexpected increase in the incidence rate of A. schaalii in abscesses, pus and tissue also suggests that A. schaalii has been overlooked as a cause of abscesses. MALDI-TOF MS is a powerful tool for identifying rare bacterial species [9,12]. The implementation of MALDI-TOF MS in routine diagnostics in most microbiological departments in Denmark has made it much easier to identify A. schaalii.…”
Section: Discussionmentioning
confidence: 99%
“…schaalii is a Gram-positive capnophilic rod, resembling the commensal coryneform bacteria on the skin and mucosa. It is difficult to identify with conventional biochemical tests, and identification often requires molecular techniques (PCR) or matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry (MS) [3,4,8,9]. A. schaalii is therefore often overlooked, and is mostly found as monocultures after 2-3 days of incubation in CO 2 [3,4,10].…”
Section: Introductionmentioning
confidence: 99%
“…The purpose of this study was to compare the performances of two commercially available MALDI-TOF MS systems, the Vitek MS in vitro diagnostic (IVD) (bioMérieux, Marcy l'Etoile, France) and MALDI Biotyper IVD (Bruker Daltonics, Wissembourg, France) systems, for the identification of relevant isolates of Actinomycetaceae. It is known that due to the thick cell wall of Gram-positive bacteria, a preliminary extraction step may be warranted before the acquisition of mass spectra, as was already shown for the Biotyper system (6)(7)(8)(9). However, to the best of our knowledge, the impact of such pretreatment has not systematically been evaluated for the Vitek MS system.…”
mentioning
confidence: 98%